These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22664127)

  • 1. Antagonists of 5-HT₆ receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Kysil VM; Mitkin OD; Vorobiev AA; Okun I
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4273-80. PubMed ID: 22664127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Dmitriev DE; Golovina ES; Dubrovskaya ES; Kadieva MG; Koryakova AG; Kysil VM; Mitkin OD; Tkachenko SE; Okun IM; Vorobiov AA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2133-6. PubMed ID: 20207539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptor.
    Ivachtchenko AV; Dmitriev DE; Golovina ES; Kadieva MG; Koryakova AG; Kysil VM; Mitkin OD; Okun IM; Tkachenko SE; Vorobiev AA
    J Med Chem; 2010 Jul; 53(14):5186-96. PubMed ID: 20560595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Mitkin OD; Tkachenko SE; Kysil VM; Okun I
    Eur J Med Chem; 2011 Apr; 46(4):1189-97. PubMed ID: 21333408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Kysil VM; Mitkin OD; Tkachenko SE; Okun IM
    J Med Chem; 2011 Dec; 54(23):8161-73. PubMed ID: 22029285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Kysil VM; Mitkin OD; Tkachenko SE; Okun I
    Bioorg Med Chem; 2011 Feb; 19(4):1482-91. PubMed ID: 21277782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile.
    Wu YJ; He H; Hu S; Huang Y; Scola PM; Grant-Young K; Bertekap RL; Wu D; Gao Q; Li Y; Klakouski C; Westphal RS
    J Med Chem; 2003 Nov; 46(23):4834-7. PubMed ID: 14584934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787.
    Andaloussi M; Lim HD; van der Meer T; Sijm M; Poulie CB; de Esch IJ; Leurs R; Smits RA
    Bioorg Med Chem Lett; 2013 May; 23(9):2663-70. PubMed ID: 23558237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 7-(2-dimethylaminovinyl) derivatives of pyrazolo[1,5-a] pyrimidines, as precursors of new tricyclic series. Binding studies of BDZ receptor.
    Bruni F; Costanzo A; Selleri S; Guerrini G; Giusti L; Martini C; Lucacchini A
    Farmaco; 1993 Feb; 48(2):309-19. PubMed ID: 8388217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.
    Hunt HJ; Belanoff JK; Golding E; Gourdet B; Phillips T; Swift D; Thomas J; Unitt JF; Walters I
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5720-5. PubMed ID: 26546213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.
    Alberti MJ; Auten EP; Lackey KE; McDonald OB; Wood ER; Preugschat F; Cutler GJ; Kane-Carson L; Liu W; Jung DK
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3778-81. PubMed ID: 15993060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
    Bioorg Med Chem; 2010 Jul; 18(14):5282-90. PubMed ID: 20541425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.
    Das J; Moquin RV; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly K; Doweyko AM; Sack JS; Zhang H; Kiefer SE; Kish K; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2652-7. PubMed ID: 18359226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
    Baraldi PG; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Romagnoli R; Moorman AR; Varani K; Borea PA; Preti D
    Bioorg Med Chem; 2012 Jan; 20(2):1046-59. PubMed ID: 22204739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF₁) receptor antagonists.
    Saito T; Obitsu T; Minamoto C; Sugiura T; Matsumura N; Ueno S; Kishi A; Katsumata S; Nakai H; Toda M
    Bioorg Med Chem; 2011 Oct; 19(20):5955-66. PubMed ID: 21930387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
    Poulsen SA; Quinn RJ
    J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists.
    Sundar BG; Bailey TR; Dunn DD; Bacon ER; Salvino JM; Morton GC; Aimone LD; Zeqi H; Mathiasen JR; Dicamillo A; Huffman MJ; McKenna BA; Kopec K; Lu LD; Brown R; Qian J; Angeles T; Connors T; Spais C; Holskin B; Galinis D; Duzic E; Schaffhauser H; Rosse GC
    Bioorg Med Chem Lett; 2012 Jan; 22(1):120-3. PubMed ID: 22153937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 7-(aminoalkyl)pyrazolo[1,5-a]pyrimidine derivatives as cathepsin K inhibitors.
    Petek N; Štefane B; Novinec M; Svete J
    Bioorg Chem; 2019 Mar; 84():226-238. PubMed ID: 30502634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists.
    Wustrow DJ; Capiris T; Rubin R; Knobelsdorf JA; Akunne H; Davis MD; MacKenzie R; Pugsley TA; Zoski KT; Heffner TG; Wise LD
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2067-70. PubMed ID: 9873487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.